These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 15477873

  • 21. [Application of proteomic approach for solid tumor marker discovery].
    Ni XG, Zhao P, Liu Y, Zhao XH.
    Ai Zheng; 2003 Jun; 22(6):664-7. PubMed ID: 12948422
    [Abstract] [Full Text] [Related]

  • 22. Proteomics in the analysis of prostate cancer.
    Naaby-Hansen S, Nagano K, Gaffney P, Masters JR, Cramer R.
    Methods Mol Med; 2003 Jun; 81():277-97. PubMed ID: 12725127
    [No Abstract] [Full Text] [Related]

  • 23. Artificial neural networks and decision tree model analysis of liver cancer proteomes.
    Luk JM, Lam BY, Lee NP, Ho DW, Sham PC, Chen L, Peng J, Leng X, Day PJ, Fan ST.
    Biochem Biophys Res Commun; 2007 Sep 14; 361(1):68-73. PubMed ID: 17644064
    [Abstract] [Full Text] [Related]

  • 24. Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research.
    You SA, Wang QK.
    Methods Mol Med; 2006 Sep 14; 129():15-26. PubMed ID: 17085802
    [Abstract] [Full Text] [Related]

  • 25. [Application of proteomics to diagnosis and treatment of lung cancer].
    Dai M, Luo RC.
    Ai Zheng; 2007 Jun 14; 26(6):669-72. PubMed ID: 17562279
    [Abstract] [Full Text] [Related]

  • 26. [Two-dimensional gel electrophoresis profiles of human normal prostate cells successfully established by 2-DE coupled with laser capture microdissection].
    Li Q, Li YL, Yang XY, Zhang HY, Li HM, Li YL.
    Zhonghua Nan Ke Xue; 2007 Dec 14; 13(12):1064-7. PubMed ID: 18284050
    [Abstract] [Full Text] [Related]

  • 27. Cancer biomarkers: knowing the present and predicting the future.
    Chatterjee SK, Zetter BR.
    Future Oncol; 2005 Feb 14; 1(1):37-50. PubMed ID: 16555974
    [Abstract] [Full Text] [Related]

  • 28. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
    Qingyi Z, Lin Y, Junhong W, Jian S, Weizhou H, Long M, Zeyu S, Xiaojian G.
    Cancer Invest; 2009 Aug 14; 27(7):794-801. PubMed ID: 19637042
    [Abstract] [Full Text] [Related]

  • 29. An introduction into proteomics and its clinical applications.
    Ahram M.
    Saudi Med J; 2007 Apr 14; 28(4):499-507. PubMed ID: 17457467
    [Abstract] [Full Text] [Related]

  • 30. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations.
    Yocum AK, Busch CM, Felix CA, Blair IA.
    J Proteome Res; 2006 Oct 14; 5(10):2743-53. PubMed ID: 17022645
    [Abstract] [Full Text] [Related]

  • 31. Mining the oncoproteome and studying molecular interactions for biomarker development by 2DE, ChIP and SPR technologies.
    Ahmed FE.
    Expert Rev Proteomics; 2008 Jun 14; 5(3):469-96. PubMed ID: 18532914
    [Abstract] [Full Text] [Related]

  • 32. Proteome analysis of a human uveal melanoma primary cell culture by 2-DE and MS.
    Pardo M, García A, Thomas B, Piñeiro A, Akoulitchev A, Dwek RA, Zitzmann N.
    Proteomics; 2005 Dec 14; 5(18):4980-93. PubMed ID: 16267820
    [Abstract] [Full Text] [Related]

  • 33. High-sensitivity analysis of human plasma proteome by immobilized isoelectric focusing fractionation coupled to mass spectrometry identification.
    Tu CJ, Dai J, Li SJ, Sheng QH, Deng WJ, Xia QC, Zeng R.
    J Proteome Res; 2005 Dec 14; 4(4):1265-73. PubMed ID: 16083276
    [Abstract] [Full Text] [Related]

  • 34. The role of electrophoresis in disease biomarker discovery.
    Issaq HJ, Veenstra TD.
    Electrophoresis; 2007 Jun 14; 28(12):1980-8. PubMed ID: 17503404
    [Abstract] [Full Text] [Related]

  • 35. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH, Rustgi AK, Blair IA.
    J Proteome Res; 2005 Jun 14; 4(5):1742-51. PubMed ID: 16212428
    [Abstract] [Full Text] [Related]

  • 36. Detection of new screening markers for fetal aneuploidies in maternal plasma: a proteomic approach.
    Reddy CS, Holzgreve W, Hahn S.
    Methods Mol Biol; 2008 Jun 14; 444():311-26. PubMed ID: 18425492
    [Abstract] [Full Text] [Related]

  • 37. Differential radioactive proteomic analysis of microdissected renal cell carcinoma tissue by 54 cm isoelectric focusing in serial immobilized pH gradient gels.
    Poznanović S, Wozny W, Schwall GP, Sastri C, Hunzinger C, Stegmann W, Schrattenholz A, Buchner A, Gangnus R, Burgemeister R, Cahill MA.
    J Proteome Res; 2005 Jun 14; 4(6):2117-25. PubMed ID: 16335957
    [Abstract] [Full Text] [Related]

  • 38. Identification and characterization of the Sulfolobus solfataricus P2 proteome.
    Chong PK, Wright PC.
    J Proteome Res; 2005 Jun 14; 4(5):1789-98. PubMed ID: 16212434
    [Abstract] [Full Text] [Related]

  • 39. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W, Mischak H, Pitt AR.
    Clin Sci (Lond); 2005 May 14; 108(5):369-83. PubMed ID: 15831087
    [Abstract] [Full Text] [Related]

  • 40. Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis.
    Vercauteren FG, Arckens L, Quirion R.
    Amino Acids; 2007 Sep 14; 33(3):405-14. PubMed ID: 17136510
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.